期刊文献+

降钙素原在消化系统疾病中的临床应用进展 被引量:1

下载PDF
导出
摘要 降钙素原(PCT)作为一种生物标志物,目前已逐步得到广泛认可及应用。PCT在机体相应机制刺激下生成较快,在血浆中结构稳定,半衰期便于监测,检测方法成熟、快捷,是临床诊疗中较为准确并具有良好运用及研究前景的指标。针对消化系统相关疾病的特点,PCT的应用正在不断完善和拓展。此文将对PCT在消化系统相关疾病中的临床应用进展作一综述。
作者 计洋洋 常江
出处 《国际消化病杂志》 CAS 2017年第1期32-33,37,共3页 International Journal of Digestive Diseases
  • 相关文献

参考文献3

二级参考文献41

  • 1赵龙凤,李红,韩德五.肠源性内毒素血症在肝硬化发生发展中的作用[J].中华肝脏病杂志,2001,9(S1):21-23. 被引量:12
  • 2Upendra R Gumaste,Mukund M Joshi,Devendra T Mourya,Pradip V Barde,Ghanshyam K Shrivastav,Vikram S Ghole.Alcohol dehydrogenase: A potential new marker for diagnosis of intestinal ischemia using rat as a model[J].World Journal of Gastroenterology,2005,11(6):912-916. 被引量:9
  • 3贾淑云,韩德五,马学惠,赵元昌,尹镭.枯否细胞功能状态对实验性急性肝功能衰竭的影响[J].肝脏病杂志,1995,3(2):80-82. 被引量:8
  • 4A.Oussalah,V.Laurent,O.Bruot,J.‐L.Guéant,D.Régent,M.‐A.Bigard,L.Peyrin‐Biroulet.Additional benefit of procalcitonin to C‐reactive protein to assess disease activity and severity in Crohn’s disease[J]. Alimentary Pharmacology & Therapeutics . 2010 (9)
  • 5Kenneth L.Becker,RichardSnider,Eric S.Nylen.Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target[J]. British Journal of Pharmacology . 2010 (2)
  • 6Andrew S. Neish.Microbes in Gastrointestinal Health and Disease[J]. Gastroenterology . 2009 (1)
  • 7Kelvin Teck-Joo Thia,Edwin Shih-Yen Chan,Khoon-Lin Ling,Wai-Yoong Ng,Edward Jacob,Choon-Jin Ooi.Role of Procalcitonin in Infectious Gastroenteritis and Inflammatory Bowel Disease[J]. Digestive Diseases and Sciences . 2008 (11)
  • 8Martijn D. Kruif,Lucienne C. Lemaire,Ida A. Giebelen,Joachim Struck,Nils G. Morgenthaler,Jana Papassotiriou,Peter J. Elliott,Tom Poll.The influence of corticosteroids on the release of novel biomarkers in human endotoxemia[J]. Intensive Care Medicine . 2008 (3)
  • 9Geert D’Haens,William J. Sandborn,Brian G. Feagan,Karel Geboes,Stephen B. Hanauer,E. Jan Irvine,Marc Lémann,Philippe Marteau,Paul Rutgeerts,Jurgen Sch?lmerich,Lloyd R. Sutherland.<ce:link locator="fx1"/> A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis[J]. Gastroenterology . 2007 (2)
  • 10Klaus R.Herrlinger,RikeDittmann,GuntherWeitz,JanWehkamp,DietherLudwig,MatthiasSchwab,Eduard F.Stange,KlausFellermann.Serum procalcitonin differentiates inflammatory bowel disease and self‐limited colitis[J]. Inflamm Bowel Dis . 2006 (3)

共引文献192

同被引文献4

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部